Amgen wins court patent ruling over Sandoz biosimilar European Pharmaceutical Review
The US District Court has decided in favour of Amgen’s Enbrel, ruling over Sandoz’s Erelzi in a patent conflict.
Amgen wins court patent ruling over Sandoz biosimilar European Pharmaceutical Review
The US District Court has decided in favour of Amgen’s Enbrel, ruling over Sandoz’s Erelzi in a patent conflict.